Agios Pharmaceuticals

AGIO

51.28

+0.37

+0.7%

Stock Price
Open: 50.91
Prev. Close: 50.91
Low/Hi: 50.61 - 51.33
52-Week: 35.84 - 67.74
Volumes
Equity: 20,877
90-Day Avg: 683,152
Option: 19
90-Day Avg: 349
Volatility
Today: 11.9
20-Day: 48.9
52-Week: 63.3
30-Day IV: 46.4 -8.1
IV Rank: 0.15 (Subdued)
Fundamental
Div. Yield: 0.0%
Earnings: 4-May
P/E Ratio:
Market Cap: 2.4 B
Stock Type: Common | Sector: Healthcare | Industry: Biotechnology

AGIO Balance Sheet

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 31-Dec-2016 30-Sep-2016 30-Jun-2016 31-Mar-2016
Cash and Cash Equivalents 160,754 285,502 234,048 39,035
Short Term Investments 380,560 293,595 231,321 273,859
Investments - - - -
Accounts Receivable 8,314 11,569 9,867 7,385
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 10,264 10,277 8,923 9,190
Net Property Plant and Equipment 25,337 26,261 25,134 22,950
Other Current Assets 0 0 0 0
Current Assets 559,892 600,943 484,159 329,469
Goodwill and Intangibles 0 0 0 0
Long Term Investments 32,250 43,499 46,926 42,860
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 619,094 672,042 557,601 396,117
Short Term Debt 0 0 0 0
Other Non-Current Assets 1,615 1,339 1,382 838
Accounts Payable 17,106 15,424 18,448 13,746
Accrued Liabilities and Other Payables 32,002 22,808 14,414 12,247
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 260,503 270,593 268,523 63,744
Other Current Liabilities 39,325 39,771 34,402 19,062
Accumulated Other Comprehensive Income -313 29 297 89
Preferred Stock 0 0 0 0
Current Liabilities 88,433 78,003 67,264 45,055
Common Stock 42 42 38 38
Other Non-Current Liabilities 172,070 192,590 201,259 18,689
Additional Paid-In Capital 842,013 828,043 652,574 640,124
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -483,151 -426,665 -363,831 -307,878
Total Equity 358,591 401,449 289,078 332,373
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014 31-Dec-2013
Cash and Cash Equivalents 160,754 71,764 14,031 71,560
Short Term Investments 380,560 245,238 328,034 95,209
Investments - - - -
Accounts Receivable 8,314 11,599 12,667 476
Inventory 0 0 0 0
Loans - - - -
Prepaid Expenses 10,264 8,728 4,814 2,502
Net Property Plant and Equipment 25,337 23,220 6,386 3,758
Other Current Assets 0 0 0 0
Current Assets 559,892 337,329 359,546 169,747
Goodwill and Intangibles 0 0 0 0
Long Term Investments 32,250 58,905 125,382 27,125
Other Assets - - - -
Long Term Receivables 0 0 0 0
Total Assets 619,094 420,065 491,904 201,205
Short Term Debt 0 0 0 0
Other Non-Current Assets 1,615 611 590 575
Accounts Payable 17,106 14,748 11,067 3,678
Accrued Liabilities and Other Payables 32,002 15,996 14,020 8,048
Long Term Debt 0 0 0 0
Other Liabilities - - - -
Current Portion of Long Term Debt 0 0 0 0
Total Liabilities 260,503 74,947 67,538 69,723
Other Current Liabilities 39,325 22,144 36,002 25,204
Accumulated Other Comprehensive Income -313 -318 -57 14
Preferred Stock 0 0 0 0
Current Liabilities 88,433 52,888 61,089 36,930
Common Stock 42 38 37 31
Other Non-Current Liabilities 172,070 22,059 6,449 32,793
Additional Paid-In Capital 842,013 630,078 591,334 244,881
Treasury Stock 0 0 0 0
Other Equity 0 0 0 0
Retained Earnings -483,151 -284,680 -166,948 -113,444
Total Equity 358,591 345,118 424,366 131,482